Oncogene - Table of Contents alert Volume 32 Issue 25

TABLE OF CONTENTS Volume 32, Issue 25 (June 2013) In this issue Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Your clear path to information.  Watch the new clinical Nature Reviews video now.   Review Top NRAS mutant melanoma: biological behavior and future strategies for therapeutic management I V Fedorenko, G T Gibney and K S M Smalley Oncogene 2013 32: 3009-3018; advance online publication, October 15, 2012; 10.1038/onc.2012.453 Abstract | Full Text Original Articles Top MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene G Ke, L Liang, J M Yang, X Huang, D Han, S Huang, Y Zhao, R Zha, X He and X Wu Oncogene 2013 32: 3019-3027; advance online publication, July 30, 2012; 10.1038/onc.2012.323 Abstract | Full Text Selection for Evi1 activation in myelomonocytic leukemia induced by hyperactive signaling through wild-type NRas S Wolf, C Rudolph, M Morgan, G Büsche, G Salguero, R Stripecke, B Schlegelberger, C Baum and U Modlich Oncogene 2013 32: 3028-3038; advance online publication, July 30, 2012; 10.1038/onc.2012.329 Abstract | Full Text Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia D W-C Chen, V Saha, J-Z Liu, J-M Schwartz and M Krstic-Demonacos Oncogene 2013 32: 3039-3048; advance online publication, August 6, 2012; 10.1038/onc.2012.321 Abstract | Full Text Integrin β5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways A Bianchi-Smiraglia, S Paesante and A V Bakin Oncogene 2013 32: 3049-3058; advance online publication, July 23, 2012; 10.1038/onc.2012.320 Abstract | Full Text Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance V Chell, K Balmanno, A S Little, M Wilson, S Andrews, L Blockley, M Hampson, P R Gavine and S J Cook Oncogene 2013 32: 3059-3070; advance online publication, August 6, 2012; 10.1038/onc.2012.319 Abstract | Full Text MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R J Gong, J-P Zhang, B Li, C Zeng, K You, M-X Chen, Y Yuan and S-M Zhuang Oncogene 2013 32: 3071-3079; advance online publication, July 23, 2012; 10.1038/onc.2012.318 Abstract | Full Text Transducer of Cdc42-dependent actin assembly promotes breast cancer invasion and metastasis H Chander, P Truesdell, J Meens and A W B Craig Oncogene 2013 32: 3080-3090; advance online publication, July 23, 2012; 10.1038/onc.2012.317 Abstract | Full Text Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas P Wang, Q Dong, C Zhang, P-F Kuan, Y Liu, W R Jeck, J B Andersen, W Jiang, G L Savich, T-X Tan, J T Auman, J M Hoskins, A D Misher, C D Moser, S M Yourstone, J W Kim, K Cibulskis, G Getz, H V Hunt, S S Thorgeirsson, L R Roberts, D Ye, K-L Guan, Y Xiong, L-X Qin and D Y Chiang Oncogene 2013 32: 3091-3100; advance online publication, July 23, 2012; 10.1038/onc.2012.315 Abstract | Full Text C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances P Muller, E Ruckova, P Halada, P J Coates, R Hrstka, D P Lane and B Vojtesek Oncogene 2013 32: 3101-3110; advance online publication, July 23, 2012; 10.1038/onc.2012.314 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.